4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-003465
President and CEO bought 6,552 shares
From the SEC's structured data for this filing
Trades in this filing
Van Hulst Jack · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2010-02-19 | Purchase : show line 1 in the form | +6,552 | 7,663 | D |
| Open-market purchases · 6,552 sh | ||||
Table II: Derivative
6 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2010-02-19 | Purchase : show line 2 in the form Common Stock Warrant | +3,792 | $1.01 | 2010-06-30 | 3,792 | 5,806 | D |
| 2010-02-19 | Purchase : show line 3 in the form Common Stock Warrant | +6,320 | $1.01 | 2012-12-20 | 6,320 | 12,126 | D |
| 2010-02-19 | Purchase : show line 4 in the form Common Stock Warrant | +4,213 | $1.01 | 2013-06-30 | 4,213 | 16,339 | D |
| 2010-02-19 | Purchase : show line 5 in the form Common Stock | +6,320 | $0.83 | 2012-12-20 | 6,320 | 22,659 | D |
| 2010-02-19 | Purchase : show line 6 in the form Common Stock Warrant | +4,213 | $0.83 | 2013-06-30 | 4,213 | 26,872 | D |
| 2010-02-19 | Purchase : show line 7 in the form Convertible Debenture Due 12/31/2010 | +0 | $0.22 | 2010-12-31 | 112,549 | 112,549 | D |
Loading xslF345X03/edgar.xml…